NCT06666582View on ClinicalTrials.gov

Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer

CompletedOBSERVATIONAL

Enrollment

185

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

March 30, 2023

Study Completion Date

January 15, 2024

Conditions

Gastric Cancer Stage IVSecond-line TreatmentRamucirumab Paclitaxel

Interventions

DRUG

Paclitaxel and ramucirumab

Second-line treatment with paclitaxel/ramucirumab vs other regimens

Trial Locations (1)

Unknown

Hellenic Oncology Cooperative Group, Athens

All Listed Sponsors

lead

Hellenic Cooperative Oncology Group

OTHER

NCT06666582 - Real-world Data of Paclitaxel and Ramucirumab Compared to Other Treatment Regimens in Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter